Analyserne bør gentages efter behov for at monitorere respons og toksicitet, men som et minimum bør en analyse foretages forud for hver behandlingscyklus.
Complete blood counts should be performed prior to initiation of therapy and as needed to monitor response and toxicity, but at a minimum, prior to each treatment cycle.